Skip to main content
. 2021 Sep 1;185(4):577–586. doi: 10.1530/EJE-21-0230

Figure 2.

Figure 2

(A and B) Survival of the patients diagnosed with a non-metastatic (A) or a metastatic insulinoma (B) in Finland during 1980–2010, compared with controls matched for age, gender, and the place of residence (log-rank test). (A) Patients with non-metastatic insulinoma vs controls (P  = 0.125), (B) patients with metastatic insulinoma vs controls (P  < 0.001).